SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
QLT PhotoTherapeutics (QLTI)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1321 51 0 QLTI
Emcee:  Doug Lakin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
96 Fire the angery doctor and find another one who understands the technology. QLTGregory Chen-4/1/1997
95 Bill, I hope that you and Jay can review some of what you know about QLT PhoJackH-4/1/1997
94 Pharmacyclics (PCYC) is another company that specializes in photodynamic therapMartin Leung-3/8/1997
93 A number of announcements were released today at "THE INTERNATIONAL PHOTOJohn K_k-3/7/1997
92 Jay, we meet again. We must follow the same stocks. On this one I strongly adviBill Tomko-2/25/1997
91 John, Yes, it all sounded pretty exciting, until I saw that an analyst had jusjay silberman-2/24/1997
90 I read the IBD article. I cut the article out but it was within a week. I foundJohn Liu-2/24/1997
89 Jenna, Did you type the IBD story, or cut & paste? When I access the IBD jay silberman-2/23/1997
88 In the NEW AMERICA section of Investor's Business Daily of Monday, FebruaryJenna2-2/22/1997
87 Steve: Looking for estimantes on QLT earnings for 1997 and beyond. You could George Mc Geary-2/20/1997
86 I thought the EPS estimates for 1997 were about $ .13 and $ .65 for 1998 in CDNSteve Wright-2/19/1997
85 A reuters story that I don't remember seeing today for info of thread: UBSIan@SI-2/19/1997
84 Sorry but a don't agree. The absolute r‚sistance was 32.85$(cdn) according Francois Plante-2/19/1997
83 In at C$24, out at C$36 (or a bit more) tommorow. This is a good company, but tDonald Gravenor-2/18/1997
82 I'll start with the 2nd question first---there was a wire story concerning Donald Gravenor-2/16/1997
81 If you are saying that the only use for Photofrin is for late stage lung cancerJoe Stephenson-2/14/1997
80 BPD for AMD is driving force behind this stock. Don I agree with your input. George Mc Geary-2/14/1997
79 Here's the scenario: A patient with advanced, inoperable (or progressive) lDonald Gravenor-2/13/1997
78 I read a news report that said QLT's SNDA with the FDA is for both early anJoe Stephenson-2/12/1997
77 I don't think this indication is driving this stock. In patients with obstrDonald Gravenor-2/12/1997
76 My understanding about the use of photofrin in esophageal cancer is that it canCindy B.-2/12/1997
75 To All, Kind of wish that I hadn't sold at $20. Check it out. Go to: biz.yGuinnessGuy-2/11/1997
74 One of the forces moving the stock is the rumor of CIBAvision looking at the coDonald Gravenor-2/8/1997
73 Right, about the sight thing, I guess. Concerning cancer treatment, the 3 biggiDonald Gravenor-2/3/1997
72 Donald, >most esophageal and lung cancers are too far advanced to benGuinnessGuy-2/2/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News